If you feel you have been harmed by Hip Replacement complications, submit your information. We are here to help.
More than 280,000 hip replacement surgeries are performed in the United States each year. Modern hip replacement methods are usually safe, effective and have fast recovery times. Many medical device companies including Johnson & Johnson, DePuY and Stryker are in fierce competition with each other to develop the most effective and widely used hip replacement components. This competition and development process has lead to many devices eventually being recalled or discontinued. The rush to create the most advanced materials and technologies for hip replacement surgeries, in some cases has left the recipients of these artificial components with complications and defective implants. If you or someone you know have suffered from pain or complications because of hip replacement implants, we are here to help. Simply fill out the form to learn more.
Common Artificial Hip Components That Have Been Recalled
Johnson & Johnson’s DePuy:
The DePuy recall came after data from a study indicated that the five year failure rate of this product is approximately 13%, or 1 in 8 patients. DePuy identified reasons for the failure of the hip replacement system as component loosening, component misalignment, infection, fracture of the bone, dislocation, metal sensitivity and pain. Additional complications may include increased metal ion levels in the blood, bone staining, necrosis, tissue damage and/or muscle damage.
Reasons for the Biomet Hip Replacement Component recall include a flawed implant, improper labeling of instructions for the surgeon and metallosis, which is metal poisoning that occurs when metal particles are released into the blood from the artificial joint. Other adverse reactions include pain, swelling, premature device failure and fracture.
In 2007, Lawrence Dorr, M.D., a nationally recognized orthopedic surgeon and a paid consultant for Zimmer, reported problems with the Durom Cup. He said that within a few months after implanting the Durom Cup in patients, the device failed and caused great pain. In some cases, he performed corrective surgery to replace the hip replacement device. He blamed the product’s “poor construction.”In 2008, Zimmer recalled the device. The FDA says the recall was because “instructions for use/surgical technique instructions were inadequate.”
The Food and Drug Administration (FDA) has received reports of more than 200 adverse events of device failures, severe pain in the hip and groin, loosening and high metal toxicity in the blood because of the metal-on-metal design of CONSERVE Plus implants. According to the National Joint Registry of England and Wales, the five-year revision rate for the CONSERVE Plus is 8.36 percent.
On July 6, 2012, after the FDA received more than 60 adverse event reports of metal toxicity requiring revision surgery, Stryker recalled its Rejuvenate and ABG II hip components in the United States and stopped all global production and sale of the devices.
The company advised patients fitted with modular-neck hip implant systems who experience persistent pain to undergo medical evaluations, including X-rays, MRIs and blood tests, to check for dangerously high metal ion levels. Medical professionals suggest that Adverse Local Tissue Reaction will generally require operative intervention and likely revision surgery with ceramic-on-metal modular junction replacement.
Smith & Nephew:
The FDA states that on June 1, 2012 Smith & Nephew Orthopaedics initiated a market withdrawal for metal liners of the R3 acetabular system due to a higher than expected number of revision surgeries associated with the use of the device in total hip replacements outside the US. Complications from these implants include pain, bone fractures and metal ions or debris being released into the body.
For more information on hip replacement recalls, you can visit FDA.gov.